S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Cash Equivalents Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Cash Equivalents
NT$27.1m
CAGR 3-Years
-1%
CAGR 5-Years
-42%
CAGR 10-Years
-18%
Y
YungShin Global Holding Corp
TWSE:3705
Cash Equivalents
NT$97.4m
CAGR 3-Years
153%
CAGR 5-Years
41%
CAGR 10-Years
-11%
Formosa Laboratories Inc
TWSE:4746
Cash Equivalents
NT$64.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ScinoPharm Taiwan Ltd
TWSE:1789
Cash Equivalents
NT$4B
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Cash Equivalents
NT$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Standard Chem & Pharm Co Ltd
TWSE:1720
Cash Equivalents
NT$503.9m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
6%

See Also

What is SCI Pharmtech Inc's Cash Equivalents?
Cash Equivalents
27.1m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Cash Equivalents amounts to 27.1m TWD.

What is SCI Pharmtech Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-18%

Over the last year, the Cash Equivalents growth was 43%. The average annual Cash Equivalents growth rates for SCI Pharmtech Inc have been -1% over the past three years , -42% over the past five years , and -18% over the past ten years .

Back to Top